These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10183301)

  • 1. An illustration of item homogeneity scaling and multilevel analysis techniques in the evaluation of drug prevention programs.
    Kreft IG
    Eval Rev; 1998 Feb; 22(1):46-77. PubMed ID: 10183301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying multilevel analytic strategies in adolescent substance use prevention research.
    Palmer RF; Graham JW; White EL; Hansen WB
    Prev Med; 1998; 27(3):328-36. PubMed ID: 9612823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling prevention program effects on growth in substance use: analysis of five years of data from the Adolescent Alcohol Prevention Trial.
    Taylor BJ; Graham JW; Cumsille P; Hansen WB
    Prev Sci; 2000 Dec; 1(4):183-97. PubMed ID: 11523747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of Drug Abuse Resistance Education (project DARE): 5-year follow-up results.
    Clayton RR; Cattarello AM; Johnstone BM
    Prev Med; 1996; 25(3):307-18. PubMed ID: 8781009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The irrelevance of evidence in the development of school-based drug prevention policy, 1986-1996.
    Gorman DM
    Eval Rev; 1998 Feb; 22(1):118-46. PubMed ID: 10183298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The social construction of "evidence-based'' drug prevention programs: a reanalysis of data from the Drug Abuse Resistance Education (DARE) program.
    Gorman DM; Huber JC
    Eval Rev; 2009 Aug; 33(4):396-414. PubMed ID: 19383841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse prevention program content: systematizing the classification of what programs target for change.
    Hansen WB; Dusenbury L; Bishop D; Derzon JH
    Health Educ Res; 2007 Jun; 22(3):351-60. PubMed ID: 16963725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The devil is in the details: examining the evidence for "proven" school-based drug abuse prevention programs.
    Gandhi AG; Murphy-Graham E; Petrosino A; Chrismer SS; Weiss CH
    Eval Rev; 2007 Feb; 31(1):43-74. PubMed ID: 17259575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zero effects in substance abuse programs. Avoiding false positives and false negatives in the evaluation of community-based programs.
    Rindskopf D; Saxe L
    Eval Rev; 1998 Feb; 22(1):78-94. PubMed ID: 10183302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of drug education and prevention programs. Disparity between impressionistic and empirical assessments.
    Gilham SA; Lucas WL; Sivewright D
    Eval Rev; 1997 Oct; 21(5):589-613. PubMed ID: 10183295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative exploratory study of substance abuse prevention outcomes in a heterogeneous prevention system.
    Clapp JD; Early TJ
    J Drug Educ; 1999; 29(3):217-33. PubMed ID: 10645124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The best of practices, the worst of practices: The making of science-based primary prevention programs.
    Gorman DM
    Psychiatr Serv; 2003 Aug; 54(8):1087-9. PubMed ID: 12883133
    [No Abstract]   [Full Text] [Related]  

  • 14. A re-evaluation of project pride, a redesigned school-based drug abuse prevention program.
    LoSciuto L; Steinman RB
    J Drug Educ; 2004; 34(2):155-66. PubMed ID: 15638216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use.
    Stephens PC; Sloboda Z; Stephens RC; Teasdale B; Grey SF; Hawthorne RD; Williams J
    Drug Alcohol Depend; 2009 Jun; 102(1-3):19-29. PubMed ID: 19362433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilevel models for hierarchically nested data: potential applications in substance abuse prevention research.
    Kreft IG
    NIDA Res Monogr; 1994; 142():140-83. PubMed ID: 9243536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsar: a qualitative study of a substance abuse prevention program.
    Martino-McAllister JM
    J Drug Educ; 2004; 34(2):89-103. PubMed ID: 15638213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peer acceleration: effects of a social network tailored substance abuse prevention program among high-risk adolescents.
    Valente TW; Ritt-Olson A; Stacy A; Unger JB; Okamoto J; Sussman S
    Addiction; 2007 Nov; 102(11):1804-15. PubMed ID: 17784893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using multilevel analyses with sibling data to increase analytic power: an illustration and simulation study.
    Krull JL
    Dev Psychol; 2007 May; 43(3):602-19. PubMed ID: 17484574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pattern-centered approach to evaluating substance use prevention programs.
    Steinman KJ; Schulenberg J
    New Dir Child Adolesc Dev; 2003; (101):87-98. PubMed ID: 15460979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.